Related Experiment Videos
[Is cardiovascular risk different in the diabetic woman?]
1Service de Diabétologie, Maladies Métaboliques et Nutrition-Hôpital Rangueil 1, avenue J. Poulhès-31403 Toulouse. hanaire.h@chu-toulouse.fr
Insights
Diabetic women face higher cardiovascular disease mortality due to diabetes negating natural protection and underuse of secondary prevention. Delayed diagnosis and treatment contribute to this increased risk in women.
Area of Science:
- Cardiology
- Endocrinology
- Gender Health
Background:
- Cardiovascular disease (CVD) is a primary cause of death in diabetic women.
- Research on CVD in women, especially diabetic women, remains limited.
- Diabetes diminishes the protective cardiovascular benefits typically seen in premenopausal women.
Purpose of the Study:
- To highlight the elevated risk of CVD mortality in diabetic women compared to men.
- To explore factors contributing to gender disparities in CVD diagnosis and treatment among diabetic patients.
- To emphasize the need for further research into CVD in diabetic women.
Main Methods:
- Review of existing literature on CVD in diabetic women.
- Analysis of gender-specific differences in risk factors, diagnosis, and treatment outcomes.
- Comparison of CVD mortality rates between diabetic men and women.
Main Results:
- Diabetic women have a higher risk of death from coronary artery disease than diabetic men.
- Non-invasive diagnostic tools for coronary artery disease are less accurate in women.
- Women are less likely to undergo invasive procedures like catheterization or revascularization, and secondary prevention treatments are underused.
Conclusions:
- Gender disparities in CVD risk among diabetics are influenced by anatomical differences and diagnostic tool accuracy.
- Delayed treatment and insufficient research on CVD in women exacerbate their increased risk.
- Addressing these gaps is crucial for improving outcomes for diabetic women.
Abstract:
Cardiovascular disease is a leading cause of mortality among diabetic women. However, studies devoted to cardiovascular disease in women, and particularly diabetic women, are scarce. Diabetes erases the natural protection of premenopausal women against cardiovascular disease. Risk of death from coronary artery disease is higher in diabetic women than in diabetic men. Diabetic women might be more exposed to some risk factors. Non invasive diagnostic tools of coronary artery disease are less accurate in women, and women are less likely than men to undergo catheterization or revascularization. The lower diameter of coronary artery might contribute to these reluctances. Nevertheless, long-term outcome of the revascularization procedures (thrombolysis, bypass graft, angioplasty) are similar in men and women, although peri-procedural risks might be higher in women. Finally, secondary prevention treatments, particularly beta-blockers, are underused in women. Gender differences in cardiovascular risk among diabetics are partly explained by discrepancies in terms of coronary artery anatomy or lack of reliable non invasive tests. But the longer delay to treatment and the lack of scientific information about the particular features of coronary heart disease in women probably contribute to the increased risk in diabetic women.